Bemis Company Announces the Election of Ms. Adele Gulfo to Its Board of Directors
June 29 2015 - 4:31PM
Business Wire
The Board of Directors of Bemis Company, Inc. (NYSE:BMS)
announced today that Adele M. Gulfo was elected to the Board of
Directors, effective June 23, 2015.
Ms. Gulfo is Chief Strategy Officer of Mylan N.V. (Nasdaq: MYL),
a leading global pharmaceutical company, since 2014. Prior to
joining Mylan, Ms. Gulfo spent four years at Pfizer, Inc., most
recently as President, Latin America, and before that as President
and General Manager, U.S. Primary Care. Previously, Ms. Gulfo held
leadership positions at AstraZeneca Pharmaceuticals, Parke-Davis
(Division of Warner-Lambert), SpectraTech Inc., and Fischer
Scientific.
“We are pleased that Adele is joining our Board of Directors,”
said William F. Austen, Bemis Company’s President and Chief
Executive Officer. “She brings valuable pharmaceutical, marketing,
and strategic insight to our board. We look forward to her
contributions and energy.”
ABOUT BEMIS COMPANY, INC.
Bemis Company, Inc. (“Bemis” or the “Company”) is a major
supplier of flexible packaging used by leading food, consumer
products, healthcare, and other companies worldwide. Founded in
1858, Bemis reported 2014 net sales from continuing operations of
$4.3 billion. Bemis has a strong technical base in polymer
chemistry, film extrusion, coating and laminating, printing, and
converting. Headquartered in Neenah, Wisconsin, Bemis employs
approximately 17,000 individuals worldwide. More information about
Bemis is available at our website, www.bemis.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150629005963/en/
Bemis Company, Inc.Erin M. Winters, 920-527-5288Director
of Investor Relations
Bemis (NYSE:BMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bemis (NYSE:BMS)
Historical Stock Chart
From Apr 2023 to Apr 2024